Skip to main navigation Skip to search Skip to main content

Identifying Potential Factors Associated with Growth Problems in Infants with Prenatal Substance Exposure

Research output: Contribution to conference › Poster › peer-review

Abstract

Objectives: The current study extends research on prenatalsubstance exposure (PSE) and infant growth by systematicallyexamining exposure to various substances and applying multi-level modeling (MLM) to evaluate the impact of PSE, feedingissues, and gastrointestinal issues on infant weight across thefirst three years of life to identify factors associated with growthproblems.Methods: A retrospective chart review (2017-2020) of in-fants with PSE (n¼240) and infants without PSE (n ¼ 209)was conducted. Over five thousand weights from the firstfour years were extracted. MLM was used to estimate howinfant weight changed over time and whether PSE, feedingissues, or gastrointestinal issues predicted different growthtrajectories over time. Weight data were fit according to thefollowing model taxonomy: Model A was the unconditionalmeans model and Model B was the unconditional growthmodel. Models C-H sequentially added level 2 predictor vari-ables one at a time as additional predictors to the uncondi-tional growth model. Model I removed non-significant fixedand random effects.Results: For the final model, weights at time 0 (birth) forinfants without substance exposure or feeding or gastrointes-tinal issues were estimated to be 4.33 kgs, on average. Infantswith opioid, THC, or benzodiazepine substance exposure hadlower estimated birth weights. Infants born premature also hadlower estimated birth weights. As expected, infant weightssignificantly increased with age. However, this increase waspredicted to be significantly less for infants with prenatal opioidexposure. Estimated infant weights did not significantly changeover time with the presence of feeding issues or gastrointestinalissues.Conclusions: Symptoms in neonates with opioid withdrawalinclude feeding and GI complications; both may impact nutrientintake and utilization. With growth among infants with opioidexposure continuing to falter over the first 3 years, identifyingthe reason has the potential to improve practice, and enhancedevelopmental outcomes. Ongoing research includes efforts tostandardize clinical documentation of symptoms for futureanalysis
Original languageEnglish
StatePublished - Jun 30 2024
EventASN Nutrition 2024 - Chicago, IL
Duration: Jun 30 2024 → Jun 30 2024

Conference

ConferenceASN Nutrition 2024
CityChicago, IL
Period6/30/24 → 6/30/24

Cite this